AZASAN Side Effects

6025770-0 | Abdominal Pain, Acute Respiratory Distress Syndrome, Blood Albumin Decreased, Blood Triglycerides Increased, Bone Marrow Failure, Condition Aggravated, Cytomegalovirus Antibody Positive, Diarrhoea, Epstein-barr Virus Infection
on Dec 18, 2008 Female patient from UNITED STATES , 15 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Azasan (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), acute respiratory distress syndrome, blood albumin decreased, blood triglycerides increased, bone marrow failure, condition aggravated, cytomegalovirus antibody positive, diarrhoea, epstein-barr virus infection. Azasan dosage: 75 Mg; Qd; Po. During the same period patient was treated with INFLIXIMAB (5 Mg/kg ; Iv) (View Infliximab Review and Infliximab Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

5928017-6 | Dysphagia, Dyspnoea, Erythema
Patient was taking Azasan (View Usage). Patient had the following side effects: dysphagia, dyspnoea, erythema on Oct 09, 2008 from UNITED STATES Additional patient health information: Female patient , 37 years of age, weighting 140.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and. Azasan dosage: 50 Mg; Qd; Po. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), ASACOL (View Asacol Review and Asacol Label ), IMODIUM /01493801/ (View Imodium /01493801/ Review and Imodium /01493801/ Label ).

5706365-2 | Dysphagia, Dyspnoea, Erythema, Petechiae, Pregnancy
Adverse event was reported on Mar 31, 2008 by a Female patient taking Azasan (View Usage) (Dosage: 50 Mg;qd;po) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 37 years of age, weighting 140.0 lb, After Azasan was administered, patient had the following side effects: dysphagia, dyspnoea, erythema, petechiae, pregnancy (What is pregnancy?). During the same period patient was treated with PREDNISONE (View Prednisone Review and Prednisone Label ), ASACOL (View Asacol Review and Asacol Label ), IMODIUM (View Imodium Review and Imodium Label ).

5599270-6 | Blood Albumin Decreased, Condition Aggravated, Crohn's Disease, Cryptogenic Organising Pneumonia, Dyspnoea, Inflammation, Lenticular Opacities, Leukocytosis
on Jan 02, 2008 Male patient from UNITED STATES , 71 years of age, was treated with Azasan (View Usage). Patient experienced the following unwanted or unexpected effects: blood albumin decreased, condition aggravated, crohn's disease (What is crohn's disease?), cryptogenic organising pneumonia, dyspnoea, inflammation, lenticular opacities, leukocytosis. Azasan dosage: 100 Mg; Qd;. During the same period patient was treated with PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.


5599269-X | Cough, Cyanosis, Dyspnoea, Hypoxia, Lobar Pneumonia, Lung Consolidation, Malaise
on Jan 02, 2008 Female patient from UNITED STATES , 43 years of age, was diagnosed with colitis ulcerative and was treated with Azasan (View Usage). Patient had the following side effects: cough, cyanosis, dyspnoea, hypoxia, lobar pneumonia, lung consolidation, malaise. Azasan dosage: 100 Mg; Qd;. During the same period patient was treated with MESALAMINE (View Mesalamine Review and Mesalamine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ). Patient was hospitalized.

5510687-8 | Dehydration, Glomerulosclerosis, Kidney Fibrosis, Meniere's Disease, Nephritis Interstitial, Pyrexia, Renal Arteriosclerosis, Renal Failure Acute, Renal Tubular Atrophy
Patient was taking Azasan (View Usage). After Azasan was administered, patient had the following side effects: dehydration, glomerulosclerosis, kidney fibrosis, meniere's disease (What is meniere's disease?), nephritis interstitial, pyrexia, renal arteriosclerosis, renal failure acute, renal tubular atrophy on Oct 29, 2007 from UNITED STATES Additional patient health information: Male patient , 33 years of age, was diagnosed with colitis ulcerative and. Azasan dosage: 50 Mg;qd;. During the same period patient was treated with COLAZAL (2.25 Gm;tid;po) (View Colazal Review and Colazal Label ), PRIMAL DEFENSE (CON.) (View Primal Defense (con.) Review and Primal Defense (con.) Label ), PREDNISONE (CON.) (View Prednisone (con.) Review and Prednisone (con.) Label ), MECLIZINE /0072801/ (CON.) (View Meclizine /0072801/ (con.) Review and Meclizine /0072801/ (con.) Label ). Patient was hospitalized.

5480733-9 | Dehydration, Nephritis Interstitial, Pyrexia, Renal Failure Acute, Renal Tubular Necrosis
Adverse event was reported on Sep 20, 2007 by a Male patient taking Azasan (View Usage) (Dosage: ) was diagnosed with colitis ulcerative and. Location: UNITED STATES , 33 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, nephritis interstitial, pyrexia, renal failure acute, renal tubular necrosis. During the same period patient was treated with COLAZAL (750 Mg, Tid; Po) (View Colazal Review and Colazal Label ), PRIMAL DIFFERENCE (View Primal Difference Review and Primal Difference Label ). Patient was hospitalized.

5405712-9 | Dehydration, Pyrexia, Renal Failure Acute, Renal Tubular Necrosis
on Jul 23, 2007 Male patient from UNITED STATES , 33 years of age, was diagnosed with colitis ulcerative and was treated with Azasan (View Usage). Patient had the following side effects: dehydration, pyrexia, renal failure acute, renal tubular necrosis. Azasan dosage: . During the same period patient was treated with COLAZAL (750 Mg; Tid; Po) (View Colazal Review and Colazal Label ). Patient was hospitalized.

5193658-3 | Extranodal Marginal Zone B-cell Lymphoma (malt Type), Gastrointestinal Disorder, Pancreatitis
on Nov 30, 2006 Female patient from UNITED STATES , 46 years of age, weighting 131.2 lb, was diagnosed with systemic lupus erythematosus and was treated with Azasan (View Usage). After Azasan was administered, patient had the following side effects: extranodal marginal zone b-cell lymphoma (malt type), gastrointestinal disorder, pancreatitis. Azasan dosage: 100 Mg; Daily. Patient was hospitalized.

5132247-3 | Anaemia, Hepatic Neoplasm Malignant, Thrombocythaemia
Patient was taking Azasan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, hepatic neoplasm malignant, thrombocythaemia on Sep 29, 2006 from UNITED STATES Additional patient health information: Female patient , 28 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Azasan dosage: 150 Mg; Daily. During the same period patient was treated with INFLIXIMAB (5 Mg/kg; Intravenous) (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

5123780-9 | Blood Amylase Increased, Lipase Increased, Pancreatitis
Adverse event was reported on Sep 27, 2005 by a Female patient taking Azasan (View Usage) (Dosage: 75 Mg Qday Po) was diagnosed with crohn's disease (What is crohn's disease?), colitis ulcerative and. Location: UNITED STATES , 35 years of age, weighting 137.0 lb, Patient had the following side effects: blood amylase increased, lipase increased, pancreatitis. During the same period patient was treated with COLAZAL (2250 Mg Tid Po) (View Colazal Review and Colazal Label ), PENTASA (View Pentasa Review and Pentasa Label ), REMICADE (View Remicade Review and Remicade Label ). Patient was hospitalized.

4775640-0 | Heart Rate Decreased, Heart Rate Increased, Oedema Peripheral
on Sep 01, 2005 Female patient from UNITED STATES , 35 years of age, weighting 131.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Azasan (View Usage). After Azasan was administered, patient had the following side effects: heart rate decreased, heart rate increased, oedema peripheral. Azasan dosage: Df. During the same period patient was treated with REMICADE (Df Iv) (View Remicade Review and Remicade Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), IRON (View Iron Review and Iron Label ), DIPHENOXYLATE W/ATROPINE SULFATE (View Diphenoxylate W/atropine Sulfate Review and Diphenoxylate W/atropine Sulfate Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), 5 ASA/MESALAZINE (View 5-asa/mesalazine Review and 5-asa/mesalazine Label ).

4693985-X | Dizziness, Syncope
on May 31, 2005 Female patient from , 36 years of age, weighting 175.0 lb, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Azasan (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), syncope. Azasan dosage: 150 Mg Qday. During the same period patient was treated with ASACOL (View Asacol Review and Asacol Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), PAMINE (View Pamine Review and Pamine Label ), ENDOCORT (View Endocort Review and Endocort Label ). Patient was hospitalized.